Evidence map›Paper›PMID 23657847›Full record

ArticlePlant foods for human nutrition (Dordrecht, Netherlands)2013

Influence of coffee brew in metabolic syndrome and type 2 diabetes.

Sheila Andrade Abrahão, Rosemary Gualberto Fonseca Alvarenga Pereira, Raimundo Vicente de Sousa, Adriene Ribeiro Lima, Gabriela Previatti Crema, Bianca Sacramento Barros

Abstract read
PubMed Publisher
In one paragraph

Article in Plant foods for human nutrition (Dordrecht, Netherlands), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Sheila Andrade AbrahãoFluminense Federal Institute, Bom Jesus do Itabapoana, RJ, Brazil. sheilanutri@yahoo.com.br
Rosemary Gualberto Fonseca Alvarenga Pereira
Raimundo Vicente de Sousa
Adriene Ribeiro Lima
Gabriela Previatti Crema
Bianca Sacramento Barros
Universidade Federal de Lavras · BRMuncipal de Bom Jesus do Itabapoana · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to evaluate the effect of coffee drinking on clinical markers of diabetes and metabolic syndrome in Zucker rats. Diabetic Zucker rats with metabolic syndrome and control Zucker rats were used for in vivo tests. The animals received daily doses of coffee drink by gavage for 30 days. After the treatment, the levels of glucose, triglycerides, total cholesterol and fractions, creatinine, uric acid, activity of aspartate aminotransferase and alanine aminotransferase were evaluated. Urea and creatinine levels were also analyzed in urine. By collaborating in the modulation of the metabolic syndrome and diabetes mellitus type 2, coffee drink helped in reducing serum glucose, total cholesterol and triglycerides. The results demonstrate that treatment with roasted coffee drink, because of its hypoglycemic and hypolipidemic effect, is efficient in the protection of animals with metabolic syndrome and diabetes mellitus type 2.

Indexed as

CoffeeAlanine TransaminaseAnimalsAspartate AminotransferasesBlood GlucoseCholesterolCholesterol, HDLCholesterol, LDLCreatinineDiabetes Mellitus, Type 2Disease Models, AnimalHypoglycemic AgentsMaleMetabolic SyndromeRatsRats, ZuckerAlanine TransaminaseAspartate AminotransferasesBlood GlucoseCholesterolCholesterol, HDLCholesterol, LDLCoffeeCreatinineHypoglycemic AgentsTriglyceridesUrea

Identifiers

PMID23657847
OpenAlexW2116139690

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.